Does Korean Skincare Meet US FDA Safety Standards? A 2026 Founder Compliance Guide

A US indie founder asked us last week: "If Korean skincare is so popular, does it actually meet the same safety rules as products already sitting on Sephora shelves?" The short answer is yes, in most cases the safety math works out — and in a few specific ingredient categories, Korean products are held to stricter standards than US brands. But the compliance stack a US founder actually inherits when they buy from a Korean ODM is more layered than most sourcing pitches admit.

Below is what MFDS (Korea's Ministry of Food and Drug Safety) actually tests, how those rules line up against FDA and MOCRA expectations, and the four supplier documents a founder should collect before signing any contract.

Key Takeaways

• MFDS regulates cosmetics through pre-market functional-cosmetic review, ingredient positive/negative lists, and mandatory stability + microbial testing — a framework closer to EU CosIng than pre-MOCRA FDA.
• The US FDA does not "approve" cosmetics. MOCRA (in effect since Dec 29, 2023) added facility registration, product listing, adverse-event reporting, and safety-substantiation records — but does not require pre-market approval.
• MFDS bans over 1,050 ingredients; FDA prohibits or restricts around 11. UV filters are the opposite direction: Korea permits ~30, the US ~16.
• For a US founder importing from Korea, four supplier documents cover most MOCRA safety-substantiation needs: MFDS product notification, ingredient CAS/INCI list, stability + PET (challenge test) reports, and Certificate of Free Sale.
• Small-business MOCRA exemptions apply to some importer-founders under $1M (FDA MOCRA small business) average annual gross sales, but do not exempt UV filters, injectables, or other regulated categories.

Is Korean Skincare Regulated as Strictly as US Cosmetics?

Korean skincare is regulated more comprehensively than US cosmetics were before MOCRA and, in several categories, still more strictly than post-MOCRA US law. MFDS operates a positive-list system for functional cosmetics (whitening, anti-wrinkle, sunscreen, hair loss, and a handful of others) that requires pre-market notification with efficacy and safety data. The US, even under MOCRA, has no pre-market approval process for cosmetics — MOCRA is a post-market records and reporting regime (FDA overview).

The practical result: a serum sold in Seoul has already cleared a documented efficacy and safety review before it ever ships. A serum sold in the US only has to meet post-market safety substantiation and adverse-event reporting standards. Korea's MFDS also runs a mandatory microbial and stability testing regime that most Korean ODMs bake into their base cost.

MFDS vs FDA: The Core Regulatory Difference

MFDS uses a pre-market notification model with defined ingredient lists. The FDA uses a post-market safety and labeling model. That single difference explains most of the practical gaps a founder will encounter.

Notice that MOCRA closed several of the historic US-Korea gaps in 2023 — but the pre-market efficacy and ingredient-list side is still uniquely Korean. That is why a Korean ODM audit trail typically has more documentation than a US-only formulator's audit trail.

Which Ingredients Are Banned in Korea but Not the US?

Korea's ingredient prohibition list is roughly 100x longer than the US list, so the more useful framing is which categories create real-world friction. Four categories consistently show up in ODM sourcing conversations.

MFDS specifically restricts or bans:

• Certain preservatives — methylisothiazolinone (MIT) restricted in leave-on products, some formaldehyde-releasers phased out; FDA still permits both with labeling.
• Specific dyes and pigments — several coal-tar-derived colorants prohibited in Korea; the FDA maintains a color-additive certification list that overlaps but is not identical (FDA Color Additive Status List).
• High-concentration acids — Korea caps consumer AHA at 10% pH 3.5+ per MFDS Cosmetic Safety Standards (MFDS); US OTC drug rules follow the CIR panel recommendation of similar caps, but there is no bright-line federal cap in general cosmetics.
• Certain UV filters — some legacy Korean filters are permitted in Korea but not in US OTC monographs, meaning a Korean SPF cannot be sold as sunscreen in the US without reformulation.

The reverse is also true: some US-permitted preservatives (like a handful of parabens the EU restricted and Korea partially followed) may or may not appear on a Korean ODM's stock formulation menu. The founder question to ask is not "is this ingredient banned?" but "which market's positive list is our base formula built against?"

The Four Safety Documents Every Korean ODM Should Provide

Four documents cover most MOCRA safety-substantiation needs for a US founder importing a Korean-manufactured product. Every reputable Korean ODM produces these as part of the standard commercial pack. If any are missing at contract-signing, treat it as a red flag.

1. MFDS product notification — proves the product is legally marketable in Korea and includes the SKU's positive-list check.
2. Full ingredient list with CAS and INCI — required for MOCRA product listing (Section 607) and for the safety substantiation file under Section 608.
3. Stability report + preservative efficacy (PET / challenge) test — MOCRA requires a "reasonable certainty" of safety under intended use; a 12-week accelerated stability plus a passing PET is the industry-standard proof.
4. Certificate of Free Sale (CFS) from MFDS — customs and US retailer compliance teams frequently request this; it is issued by MFDS on the exporter's request and typically takes 1–2 weeks.

A fifth optional document — a Certificate of Analysis for each batch — is worth requesting for the first three production runs even if the ODM does not include it by default.

I'm Liz Song, and I run ALTA MEET from Manhattan, NYC, matching US indie founders with Korean ODMs. The pattern I see most often: a founder signs a quote sheet, gets the product, and then scrambles to build a MOCRA safety file after the fact. Every one of the four documents above is easier to negotiate into a contract than to request retroactively. If you want a 15-minute gut-check on whether your current supplier package covers MOCRA, I'll do it free — calendly.com/liz-altameet/gut-check or email liz@altameet.com.

Does MOCRA Change How US Founders Evaluate Korean Suppliers?

MOCRA changed the paperwork burden on the US-side importer, not on the Korean manufacturer. A US founder now carries the legal obligation to register the importing facility (or nominate the "Responsible Person"), list every product, maintain safety substantiation records, and report serious adverse events within 15 business days.

What that means for supplier evaluation:

• The Responsible Person is you, not the ODM. MOCRA Section 605 requires a US-based Responsible Person on the label. That role cannot be delegated to a Korean factory.
• You need supplier-side documentation to build your safety file. The four documents above are the minimum inputs; without them you cannot meet the "reasonable certainty of safety" standard.
• Adverse event reporting requires supplier cooperation. If a consumer reports a serious event, you need the ODM's batch records and stability data within days, not weeks.
• Facility registration is separate from ODM selection. The Korean ODM does not register with FDA on your behalf — you register your own US importing entity.

For a comparison of the founder-side MOCRA workflow across markets, see the MOCRA small-business exemption guide and the FDA Korean skincare import guide.

Founder Compliance Checklist: What to Verify Before Signing an ODM Contract

A concrete, sign-off-ready checklist for the safety compliance side of a Korean ODM contract. Print it, walk through it with the supplier, and get initials on every line.

1. ODM holds a valid MFDS Cosmetics Manufacturer License (verify license number on MFDS site).
2. Formula is confirmed compliant with US OTC monograph if it contains sunscreen or drug claims.
3. Ingredient list is fully INCI + CAS mapped, with no proprietary "trade secret" placeholders.
4. Stability report covers minimum 12 weeks accelerated (40°C / 75% RH) per ICH Q1A(R2) with pass criteria documented.
5. PET / preservative challenge test passes USP 51 or ISO 11930 acceptance criteria.
6. Certificate of Free Sale can be issued within 2 weeks of production for each exported SKU.
7. Certificate of Analysis is provided per batch (negotiate this in even if it's not standard).
8. ODM confirms adverse-event data will be released within 5 business days on request.
9. Any ingredient on the US restricted or MOCRA-monitored list is called out in the quote with substitution options.
10. MSDS / SDS is available for all raw materials for shipping compliance.

Founders working on retailer submissions should also confirm whether Sephora, Ulta, or Amazon have retailer-specific ingredient exclusions that go beyond MOCRA — for a breakdown, see the complete K-beauty launch guide.

Frequently Asked Questions

Does the FDA approve Korean skincare products?

The FDA does not approve any cosmetics — Korean or otherwise. Cosmetics are regulated post-market under MOCRA, meaning brands must register their facility, list their products, and maintain safety substantiation records, but no pre-market approval is required. Sunscreens and drug-claim products are the exception; those follow OTC monograph rules that do involve FDA review.

Do I need a US agent or Responsible Person to import Korean skincare?

Every cosmetic sold in the US must have a US-based Responsible Person named on the label, per MOCRA Section 605. For a founder importer, this is usually your own US entity. The Korean ODM cannot serve as your Responsible Person because the role requires a US mailing address that accepts FDA correspondence.

Are MFDS stability tests accepted by the FDA?

Yes, MFDS stability data is generally accepted as evidence for MOCRA safety substantiation, provided the report includes accelerated conditions (typically 40°C at 75% relative humidity for 12 weeks per ICH Q1A(R2)) with documented pass criteria. FDA does not certify foreign lab reports, but the "reasonable certainty of safety" standard permits well-documented supplier testing.

What happens if my Korean supplier uses a UV filter not approved in the US?

You cannot sell that product as a sunscreen in the US. It can be sold as a general skincare product only if all sunscreen claims are removed from the label and marketing. If SPF is part of your brand promise, the formula must be rebuilt against the US OTC sunscreen monograph, which permits roughly 16 filters versus Korea's ~30.

Does the MOCRA small-business exemption cover imported Korean products?

Partially. Businesses with average annual gross sales under $1 million qualify for exemption from facility registration and product listing requirements (FDA MOCRA small business). Adverse-event reporting and safety substantiation still apply. Sunscreens, injectables, and products making drug claims are excluded from the exemption regardless of company size.

The Bottom Line for Founders

Korean skincare typically arrives in the US with more supporting documentation than a US-only manufactured product because MFDS requires pre-market data that the FDA does not. The founder's job is to (a) collect the four supplier documents at contract-signing, (b) name a US Responsible Person on the label, and (c) build the MOCRA safety substantiation file before the first shipment lands — not after a consumer complaint.

If you'd like a 15-minute gut-check on whether your current or prospective Korean ODM has the paperwork MOCRA expects, book a free call at calendly.com/liz-altameet/gut-check or email liz@altameet.com. We can walk through your quote sheet and flag the gaps before you sign.

By Liz Song, K-beauty sourcing consultant | 7+ years bridging Korean ODMs and US indie brands. Reviewed for accuracy by ALTA MEET's formulation consulting team.